Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2876
Preferred Bank
PFBC
$1.26B
| $2.09M | ﹤0.01% |
22,131
+4,419
| +25% | +$412K |
2016 Q3
37 quarters
|
|
|
TBPH
2877
DELISTED
Theravance Biopharma
TBPH
| $2.09M | ﹤0.01% |
111,619
-3,772
| -3% | -$62.6K |
2014 Q2
46 quarters
|
|
2878
Nice
NICE
$6.67B
| $2.08M | ﹤0.01% |
18,418
+16,608
| +918% | +$2.01M |
2016 Q1
39 quarters
|
|
2879
Cadre Holdings
CDRE
$1.07B
| $2.08M | ﹤0.01% |
50,943
+3,193
| +7% | +$133K |
2022 Q1
15 quarters
|
|
2880
Geron
GERN
$771M
| $2.08M | ﹤0.01% |
1,575,429
-360,177
| -19% | -$452K |
2013 Q2
50 quarters
|
|
2881
PC Connection
CNXN
$2.33B
| $2.08M | ﹤0.01% |
35,986
+1,894
| +6% | +$113K |
2016 Q3
37 quarters
|
|
|
SILA
2882
DELISTED
Sila Realty Trust
SILA
| $2.08M | ﹤0.01% |
89,045
+8,437
| +10% | +$198K |
2024 Q3
5 quarters
|
|
2883
Sana Biotechnology
SANA
$865M
| $2.08M | ﹤0.01% |
509,889
-15,967
| -3% | -$71.5K |
2022 Q1
15 quarters
|
|
2884
PUT
Cisco
CSCO
$442B
| $2.07M | ﹤0.01% |
26,900
-100,000
| -79% | -$7.42M |
2025 Q2
2 quarters
|
|
|
EFC
2885
Ellington Financial
EFC
$1.49B
| $2.07M | ﹤0.01% |
152,491
+22,430
| +17% | +$305K |
2022 Q1
15 quarters
|
|
2886
ZipRecruiter
ZIP
$292M
| $2.07M | ﹤0.01% |
530,744
+7,010
| +1% | +$31.5K |
2022 Q1
15 quarters
|
|
2887
Omeros
OMER
$1.35B
| $2.07M | ﹤0.01% |
120,490
-11,458
| -9% | -$98.7K |
2013 Q2
50 quarters
|
|
|
THS
2888
DELISTED
Treehouse Foods
THS
| $2.06M | ﹤0.01% |
87,406
-88,391
| -50% | -$1.93M |
2013 Q2
50 quarters
|
|
2889
Zillow
ZG
$6.32B
| $2.06M | ﹤0.01% |
30,216
+6,858
| +29% | +$482K |
2013 Q2
50 quarters
|
|
2890
Herbalife
HLF
$1.32B
| $2.06M | ﹤0.01% |
159,600
+16,740
| +12% | +$177K |
2013 Q4
48 quarters
|
|
2891
CALL
Arista Networks
ANET
$262B
| $2.06M | ﹤0.01% |
15,700
-19,000
| -55% | -$2.62M |
2025 Q2
2 quarters
|
|
2892
Mercantile Bank Corp
MBWM
$1.03B
| $2.05M | ﹤0.01% |
42,713
+13,098
| +44% | +$604K |
2016 Q2
38 quarters
|
|
2893
Energizer
ENR
$1.51B
| $2.05M | ﹤0.01% |
103,225
+5,719
| +6% | +$125K |
2015 Q3
41 quarters
|
|
2894
Hayward Holdings
HAYW
$2.63B
| $2.05M | ﹤0.01% |
132,462
+50,568
| +62% | +$799K |
2022 Q1
15 quarters
|
|
2895
CALL
Moody's
MCO
$76.4B
| $2.04M | ﹤0.01% |
4,000
-600
| -13% | -$293K |
2025 Q1
3 quarters
|
|
2896
PUT
Fastly Inc
FSLY
$4.11B
| $2.04M | ﹤0.01% |
200,000
| – | – |
2024 Q3
5 quarters
|
|
2897
F&G Annuities & Life
FG
$2.87B
| $2.03M | ﹤0.01% |
65,828
+35,847
| +120% | +$1.12M |
2022 Q4
12 quarters
|
|
2898
Astec Industries
ASTE
$967M
| $2.03M | ﹤0.01% |
46,878
+6,706
| +17% | +$306K |
2013 Q2
50 quarters
|
|
2899
CALL
Lowe's Companies
LOW
$101B
| $2.03M | ﹤0.01% |
8,400
-329,000
| -98% | -$79M |
2023 Q2
10 quarters
|
|
2900
Ouster
OUST
$3.2B
| $2.03M | ﹤0.01% |
93,582
+8,059
| +9% | +$213K |
2023 Q3
9 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.